Clinical Biochemical Genetics · Seattle, WA
NPI
1336370758
Since 2009
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1959 NE Pacific St
Seattle, WA, 98195
Phone (206) 598-4317
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,750
85 services
Medicare patients, 2024
53
Average age 60
Drug cost, 2024
$871K
69 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sirisak Chanprasert was code 99205 (office e&m - new), 28 times for 28 patients. In total Sirisak Chanprasert billed 85 services in 7 codes, and Medicare paid $6,750.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99205 Office E&M - New | Facility | 28 | 28 | $118.45 | $3,317 |
| 99215 Office E&M - Established | Facility | 25 | 23 | $107.83 | $2,696 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 25 | 23 | $13.47 | $337 |
By year: 2022 $8,264 for 81 services; 2023 $8,870 for 69 services; 2024 $6,750 for 85 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sirisak Chanprasert prescribed most often to Medicare patients was Galafold (Migalastat Hcl), with 27 prescriptions and refills. In total Sirisak Chanprasert wrote 69 Medicare prescriptions that cost $871K.
Brand drugs: 47 claims; generic drugs: 22 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sirisak Chanprasert $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.